Will Pharma Embrace Open Innovation?
The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of drug development. So what’s the alternative? Recently,
Comments Off on Will Pharma Embrace Open Innovation? • Read this story »